EAACI Congress 2024
BackAllergen immunotherapy 4
Saturday 01 Jun, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
12:00
Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander
12:00
An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)
12:00
Clinical and immunological comparison between two subcutaneous immunotherapy products in children with allergic rhinitis
12:00
Evaluation of auditory function in children with allergic rhinitis treated with specific immunotherapy
12:00
Immunological changes induced by a salsola kaly extract in patients with allergic rhinitis or rhinitis and asthma
12:00
Is the use of anti-hypertensive medication safe during hymenoptera venom immunotherapy?
12:00
Real-life Non-interventional Post authorization Safety Study with the SQ tree sublingual immunotherapy tablet
12:00
Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy
12:00
Sublingual dust mite allergen immunotherapy reduces respiratory infections in children with allergic rhinitis
12:00
Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre
12:00
Using the AllergyVax app to increase adherence to allergen subcutaneous immunotherapy
